STOCK TITAN

Planned 1,780-share sale by Company (NASDAQ: APLS) under Rule 144

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

A shareholder filed a Rule 144 notice to sell 1,780 shares of common stock through Fidelity Brokerage Services LLC on or about 01/13/2026, with an indicated aggregate market value of 39,493.22. The planned sale is listed for trading on NASDAQ, and the table notes that there were 126,525,218 shares outstanding when the form was prepared.

The shares to be sold were acquired on 01/12/2026 via a restricted stock vesting transaction from the issuer, described as compensation. The signer represents that they are not aware of any undisclosed material adverse information about the issuer’s current or prospective operations.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does this Form 144 filing related to APLS disclose?

It discloses a planned sale of 1,780 shares of common stock under Rule 144, including how the shares were acquired and basic trading details such as broker, exchange, and timing.

How many APLS shares are planned to be sold and at what market value?

The notice covers 1,780 shares of common stock with an indicated aggregate market value of 39,493.22 at the time the form was prepared.

How and when were the APLS shares being sold under Rule 144 acquired?

The shares were acquired on 01/12/2026 through restricted stock vesting from the issuer, described as compensation in the filing.

Through which broker and on which exchange are the APLS shares expected to be sold?

The filing lists Fidelity Brokerage Services LLC as broker and indicates that the shares are to be sold on NASDAQ.

What is the approximate sale date for the APLS shares in this Form 144?

The table shows an approximate date of sale of 01/13/2026 for the 1,780 shares covered by the notice.

How many APLS shares were outstanding when this Rule 144 notice was prepared?

The securities information section lists 126,525,218 shares outstanding of the issuer’s common stock at the time of the notice.

What representation does the seller make about information on APLS?

By signing, the seller represents that they do not know of any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed.
Apellis Pharmace

NASDAQ:APLS

APLS Rankings

APLS Latest News

APLS Latest SEC Filings

APLS Stock Data

2.60B
106.62M
13.68%
105.74%
16.26%
Biotechnology
Pharmaceutical Preparations
Link
United States
WALTHAM